INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Zenas ...

INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Zenas BioPharma - Zenas BioPharma (NASDAQ:ZBIO)

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Zenas To Contact Him Directly To Discuss Their Options If you purchased or otherwise acquired stock of Zenas pursuant and/or traceable to Zenas' registration statement for the initial public offering held on or about September 13, 2024 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at …

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Zenas ...

NEW YORK, April 25, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Zenas BioPharma, Inc. (“Zenas” or the “Company”) (NYSE: ZBIO). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or…

NASDAQ: ZYXI DEADLINE REMINDER: Berger Montague Reminds Zynex (NASDAQ: ZYXI) Investors of Important Class Action Lawsuit Deadline

PHILADELPHIA, April 24, 2025 /PRNewswire/ -- Berger Montague PC advises investors that a securities class action lawsuit has been filed against Zynex, Inc. ("Zynex" or the "Company") (NASDAQ: ZYXI) on behalf of purchasers of Zynex securities between March 13, 2023…

# Investors in Zenas BioPharma Urged to Act Before Deadline Amid Allegations of Misleading Information

In a significant development for investors in Zenas BioPharma, Inc. (NASDAQ: ZBIO), Rosen Law Firm, a prominent global investor rights law firm, is urging shareholders to secure legal counsel ahead of a critical deadline in a securities class action lawsuit. This comes on the heels of important filings related to the company's initial public offering (IPO) that took place in September 2024. As the legal landscape around Zenas BioPharma evolves, …